BBIO
BBIO
NASDAQ · Biotechnology

Bridgebio Pharma Inc

Large-Cap Stocks Blue Chip Stocks Biotech Stocks Healthcare Stocks
$68.63
-0.29 (-0.42%)
As of Jun 23, 9:42 PM ET ·
Analyst Consensus
Strong Buy
29
Analysts
High
Coverage
Buy 27 93%
Hold 2 7%
Sell 0 0%
Price Target
Analyst Price Target +176.9% upside
Low Target $141.92
Average Target $190.06
High Target $243.96
Current Price $68.63
Current
$68.63
Target
$190.06
$141.92 $190.06 avg $243.96
Scenario Analysis
Bear Case
$141.92
106.8%
Low target
Base Case
$190.06
+176.9%
Avg target
Bull Case
$243.96
+255.5%
High target
Risk/Reward
2.4x
Favorable
Price in Context
52-Week High
$84.94
-19.2% from high
52-Week Low
$39.65
+73.1% from low
50-Day SMA
$75.38
-9.0% vs SMA
200-Day SMA
$56.39
+21.7% vs SMA
RSI (14)
38.4
Neutral
Target vs 52W High
$190.06
+123.8% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
 Strong Buy 40 78% $257.58 +9.7%
AMGN
Amgen Inc
 Hold 44 50% $190.87 -45.0%
GILD
Gilead Sciences Inc
 Strong Buy 39 82% $362.68 +190.0%
VRTX
Vertex Pharmaceuticals Inc
 Strong Buy 40 83% $438.34 -6.4%
REGN
Regeneron Pharmaceuticals
 Buy 38 71% $76.80 -87.6%
ALNY
Alnylam Pharmaceuticals Inc
 Strong Buy 37 76% $102.31 -64.5%
RVMD
Revolution Medicines Inc
 Strong Buy 27 96% $114.11 -32.7%
NTRA
Natera Inc
 Strong Buy 27 89% $142.91 -39.1%